Search Results - Alberto Suárez Zaizar

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    LBA8 Phase III study of cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC) of IMDC intermediate or poor risk (COSMIC-313)

    LBA8 Phase III study of cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC) of IMDC intermediate or p... by Toni K. Choueiri, Tom Powles, Laurence Albigès, M. Burotto, C. Szczylik, B. Zurawski, E. Yanez Riuz, Marco Maruzzo, Alberto Suárez Zaizar, Luis Fein, Fabio A. Schutz, Daniel Yick Chin Heng, F. Wang, Fabio Mataveli, Yih‐Leong Chang, Maximiliano van Kooten Losio, C. Suárez Rodríguez, Robert J. Motzer

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

    Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma by Toni K. Choueiri, Thomas Powles, Laurence Albigès, Mauricio Burotto, Cezary Szczylik, Bogdan Żurawski, Eduardo Yañez Ruiz, Marco Maruzzo, Alberto Suárez Zaizar, Luis Fein, Fabio A. Schutz, Daniel Y.C. Heng, Fong Wang, Fabio Mataveli, Yu-Lin Chang, Maximiliano van Kooten Losio, Cristina Suárez, Robert J. Motzer

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    LBA20 A randomized, double-blind trial of nivolumab (NIVO) vs placebo (PBO) with neoadjuvant chemotherapy (NACT) followed by adjuvant endocrine therapy (ET) ± NIVO in patients (pts) with high-risk, ER+ HER2− primary breast cancer (BC)

    LBA20 A randomized, double-blind trial of nivolumab (NIVO) vs placebo (PBO) with neoadjuvant chemotherapy (NACT) followed by adjuvant endocrine therapy (ET) ± NIVO in patients (pts... by Sherene Loi, Giuseppe Curigliano, Roberto Salgado, Roberto Iván Romero Díaz, Suzette Delaloge, C. Rojas, Marleen Kok, C. Saura Manich, Nadia Harbeck, Elizabeth A. Mittendorf, Denise A. Yardley, Lajos Pusztai, Alberto Suárez Zaizar, Aurelian Ungureanu, Felipe Ades, R. Chandra, Raheel Nathani, Misena Pacius, Jintong Wu, Heather L. McArthur

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial

    Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial by Sherene Loi, Roberto Salgado, Giuseppe Curigliano, Roberto Iván Romero Díaz, Suzette Delaloge, Carlos Ignacio Rojas García, Marleen Kok, Cristina Saura, Nadia Harbeck, Elizabeth A. Mittendorf, Denise A. Yardley, Alberto Suárez Zaizar, Facundo Rufino Caminos, Andrei Ungureanu, Joaquin G. Reinoso-Toledo, Valentina Guarneri, Daniel Egle, Felipe Ades, Misena Pacius, Aparna Chhibber, Rajalakshmi Chandra, Raheel Nathani, Thomas E. Spires, Jenny Wu, Lajos Pusztai, Heather L. McArthur

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: